Dr. Michael Everest Makes A Difference By Funding Medical Education Initiatives

    NEXT STORY
    How Cancer Patients Feel About Novel Medication Adherence Programs
    PREV STORY
    World Genetic Testing Industry Assessment 2019-2023: Volumes, Prices and Revenues by Test
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Atara Biotherapeutics Announces First Quarter 2017 Financial Results and Recent Highlights

    SOUTH SAN FRANCISCO, Calif., May 04, 2017 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA) ...

    author_avatar
    NASDAQ Market News

    G1 Therapeutics to Present Additional Trilaciclib Phase 2 Small Cell Lung Cancer Data at 2019 American Society of Clinical Oncology (ASCO) Annual Meeting

    author_avatar
    NASDAQ Market News

    Caladrius Biosciences Announces the Resignation of Joseph Talamo, Chief Financial Officer

    author_avatar
    NASDAQ Market News